Applied Genetic Technologies reported $110.41M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alimera Sciences ALIM:US $ 60.06M 2.04M
Applied Genetic Technologies AGTC:US $ 110.41M 16.56M
Avrobio Inc AVRO:US $ 216.45M 21.64M
Biogen BIIB:US $ 23806.7M 663.7M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Celldex Therapeutics CLDX:US $ 460.2M 255.65M
Cti Biopharma CTIC:US $ 101.23M 23.74M
Gilead Sciences GILD:US $ 67098M 886M
Insmed INSM:US $ 1.31B 81.99M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
Life Technologies LIFE:US $ 123.92M 74.92M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Rigel Pharmaceuticals RIGL:US $ 186.52M 15.08M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M